Mastaplex Limited

Based in New Zealand, and founded in 2013, Mastaplex Limited operates as a veterinary diagnostics company. The company was founded by its CEO Olaf Bork. In July 2022, Mastaplex raised USD 0. 70 million in venture funding from unspecified investors.

Mastaplex product line includes Mastatest, which is a point-of-care on-farm mastitis diagnostic tool that consists of cartridges, Lapbox, and a console that is used by veterinarians to diagnose bovine mastitis. The company offers a patented technology that identifies bacterial strains in cows in three different processes: loading a cartridge, which is a tool that allows users to add milk samples to the cartridge and then place that cartridge into a Lapbox, and the last process, in which farmers will get test results in 24 hours. The company plans to use the funds raised in July 2022 to expand its business in New Zealand and Australia and launch its product into international dairy markets including the UK, EU, and the US.